Examples of using Hepatic dysfunction in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
The safety and efficacy of ViraferonPeg therapy has not been evaluated in patients with severe hepatic dysfunction, therefore ViraferonPeg must not be used for these patients.
Significant or unexplained hepatic dysfunction.• Active peptic ulcer disease.• Arterial bleeding.
Dynastat should be used with caution in patients with moderate hepatic dysfunction(Child-Pugh score 7-9)
values for subjects with mild hepatic dysfunction were up to 1.4 times greater than those for subjects with normal hepatic function.
serious hepatic dysfunction and yellowing of the eyes of skin.
The safety and efficacy of erlotinib has not been studied in patients with severe hepatic dysfunction AST/SGOT and ALT/SGPT>
Iloprost elimination is reduced in patients with hepatic dysfunction and in patients with renal failure requiring dialysis see section 5.2.
The pharmacokinetics of afatinib have not been studied in subjects with severe(Child Pugh C) hepatic dysfunction see section 4.4.
Use of Tarceva in patients with severe hepatic dysfunction is not recommended see section 5.2.
If any patient develops symptoms suggesting hepatic dysfunction, which may include unexplained nausea,
Liver enzyme monitoring should be considered for patients without pre-existing hepatic dysfunction or other risk factors.
toxic products of bacterial transformations which affect the respiratory failure, hepatic dysfunction, reduce fitness,
osteoporosis, hepatic dysfunction and arteriosclerosis.
enzymatic cleavage in the plasma, hepatic dysfunction is very unlikely to alter its systemic exposure.
In smoking subjects with mild hepatic dysfunction, mean elimination half-life(39.3 hr) was prolonged and clearance(18.0 l/ hr)
was significantly decreased by renal impairment and hepatic dysfunction, but the magnitude of the differences in clearance(<
at Cycle 3 after repeated dosing in patients with mild or moderate hepatic dysfunction was within the range observed in patients with normal hepatic function.
Severe liver function test abnormalities(Grade 3 to 4) and hepatic dysfunction with clinical manifestations(including fatal outcomes)
compromised circulation and hepatic dysfunction.
Although cases of hepatic dysfunction(elevated aminotransferase with increase in bilirubin or International Normalized Ratio[INR])